Sanofi (SNY) Intangibles (2009 - 2026)

Sanofi has disclosed Intangibles across 18 years of filings, most recently posting $80.9 billion for Q1 2026.

• Intangibles for Q1 2026 came in at $80.9 billion, up 20.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $80.9 billion (up 20.5% YoY), and the FY2025 annual result was $78.6 billion, up 225.23% from the prior year.
• Intangibles came in at $80.9 billion for Q1 2026 at Sanofi, up from $78.6 billion in the prior quarter.
• In the past five years, Intangibles ranged from a high of $80.9 billion in Q1 2026 to a low of $22.1 billion in Q4 2022.
• The 5-year median for Intangibles is $67.1 billion (2025), against an average of $54.2 billion.
• Across the five-year window, Intangibles retreated 9.84% in 2022 and soared 225.23% in 2025, its largest moves.
• Sanofi's Intangibles stood at $22.1 billion in 2022, then advanced by 18.51% to $26.2 billion in 2023, then slipped by 7.58% to $24.2 billion in 2024, then jumped by 225.23% to $78.6 billion in 2025, then rose by 2.85% to $80.9 billion in 2026.
• The last three Intangibles figures came in at $80.9 billion (Q1 2026), $78.6 billion (Q4 2025), and $80.5 billion (Q3 2025), per Business Quant data.